Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study

References

• Szendroi M. Giant-cell tumour of bone. J Bone Joint Surg Br 2004;86:5–12.
   PubMed Web of Science ®Google Scholar
• Skubitz KM, Cheng EY, Clohisy DR, Thompson RC, Skubitz AP. Gene expression in giant-cell tumors. J Lab Clin Med 2004;144:193–200.
   PubMed Web of Science ®Google Scholar
• Raskin KA, Schwab JH, Mankin HJ, Springfield DS, Hornicek FJ. Giant cell tumor of bone. J Am Acad Orthop Surg 2013;21:118–26.
   PubMed Web of Science ®Google Scholar
• Thomas DM, Skubitz KM. Giant cell tumour of bone. Curr Opin Oncol 2009;21:338–44.
   PubMed Web of Science ®Google Scholar
• Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, et al. Denosumab in patients with giant-cell tumour of bone: An open-label, phase 2 study. Lancet Oncol 2010; 11:275–80.
   PubMed Web of Science ®Google Scholar
• Malone S, O’Sullivan B, Catton C, Bell R, Fornasier V, Davis A. Long-term follow-up of efficacy and safety of megavoltage radiotherapy in high-risk giant cell tumors of bone. Int J Radiat Oncol Biol Phys 1995;33:689–94.
   PubMed Web of Science ®Google Scholar
• Shi W, Indelicato DJ, Reith J, Smith KB, Morris CG, Scarborough MT, et al. Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol 2013;36:505–8.
   PubMed Web of Science ®Google Scholar
• Chakravarti A, Spiro IJ, Hug EB, Mankin HJ, Efird JT, Suit HD. Megavoltage radiation therapy for axial and inoperable giant-cell tumor of bone. J Bone Joint Surg Am 1999;81:1566–73.
   PubMed Web of Science ®Google Scholar
• Ruka W, Rutkowski P, Morysinski T, Nowecki Z, Zdzienicki M, Makula D, et al. The megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of bone. Int J Radiat Oncol Biol Phys 2010;78:494–8.
   PubMed Web of Science ®Google Scholar
• Atkins GJ, Kostakis P, Vincent C, Farrugia AN, Houchins JP, Findlay DM, et al. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res 2006;21:1339–49.
   PubMed Web of Science ®Google Scholar
• Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, et al. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res 2012;18:4415–24.
   PubMed Web of Science ®Google Scholar
• Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, et al. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 2004;19:1059–66.
   PubMed Web of Science ®Google Scholar
• Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: Interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol 2013;14:901–8.
   PubMed Web of Science ®Google Scholar
• Cleeland CS. Pain assessment in cancer. In: Osaba D, editor. Effect of cancer on quality of life. Boca Raton, Fl: CRC Press; 1991.
   Google Scholar
• Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277–84.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371–83.
   PubMed Web of Science ®Google Scholar
• Mathias SD, Crosby RD, Qian Y, Jiang Q, Dansey R, Chung K. Estimating minimally important differences for the worst pain rating of the Brief Pain Inventory-Short Form. J Support Oncol 2011;9:72–8.
   PubMedGoogle Scholar
• Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care 2003; 41:582–92.
   PubMed Web of Science ®Google Scholar
• Chung KC, Barlev A, Braun AH, Qian Y, Zagari M. Assessing analgesic use in patients with advanced cancer: Development of a new Scale-The Analgesic Quantification Algorithm. Pain Med 2014;15:225–32.
   PubMed Web of Science ®Google Scholar
• Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001;413:203–10.
   PubMed Web of Science ®Google Scholar
• Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nat Rev Cancer 2002;2:201–9.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9–19.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, et al. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain 2009;146: 238–44.
   PubMed Web of Science ®Google Scholar
• Balke M, Campanacci L, Gebert C, Picci P, Gibbons M, Taylor R, et al. Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone. BMC Cancer 2010;10:462.
   PubMed Web of Science ®Google Scholar
• Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: A case-control study. Bone 2008;42:68–73.
   PubMed Web of Science ®Google Scholar
• Gille O, Oliveira Bde A, Guerin P, Lepreux S, Richez C, Vital JM. Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapy. Spine (Phila Pa 1976) 2012;37:E396–9.
   Web of Science ®Google Scholar
• Chaudhary P, Khadim H, Gajra A, Damron T, Shah C. Bisphosphonate therapy is effective in the treatment of sacral giant cell tumor. Onkologie 2011;34:702–4.
   PubMedGoogle Scholar
• Roeder F, Timke C, Zwicker F, Thieke C, Bischof M, Debus J, et al. Intensity modulated radiotherapy (IMRT) in benign giant cell tumors – a single institution case series and a short review of the literature. Radiat Oncol 2010;5:18.
   PubMed Web of Science ®Google Scholar
• Rock MG, Sim FH, Unni KK, Witrak GA, Frassica FJ, Schray MF, et al. Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients. J Bone Joint Surg Am 1986;68:1073–9.
   PubMedGoogle Scholar
• Beecher HK. The powerful placebo. J Am Med Assoc 1955;159:1602–6.
   PubMed Web of Science ®Google Scholar
• Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994;271:1609–14.
   PubMed Web of Science ®Google Scholar
• Linde K, Fassler M, Meissner K. Placebo interventions, placebo effects and clinical practice. Philos Trans R Soc Lond B Biol Sci 2011;366:1905–12.
   PubMed Web of Science ®Google Scholar